{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:15:02Z","timestamp":1785813302692,"version":"3.56.0"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The methylated resveratrol analogue 3\u2032-hydroxy-3,4,5,4\u2032-tetramethoxystilbene (DMU-214) has been revealed to exert the anti-cancer activity by a block of the cell cycle at the G2\/M phase, apoptosis induction, and metastasis inhibition. These biological events may be involved in crosstalk with the epidermal growth factor receptor (EGFR), which belongs to the ErbB family of receptor tyrosine kinases. Several cancer therapeutic approaches employ small molecules capable of inhibiting tyrosine kinases (e.g., gefitinib). According to more recent reports, combining gefitinib with chemotherapeutics, such as cisplatin, seems to be more effective than monotherapy. The present study aimed to assess the molecular mechanism of the potential anti-proliferative activity of individual and combined treatments with DMU-214 and gefitinib in SCC-25 and CAL-27 human tongue cancer cell lines. We showed for the first time the anti-cancer effects of DMU-214, gefitinib, and their combination in tongue cancer cells triggered via cell cycle arrest, apoptosis induction, and inhibition of the EGFR signaling pathway. The anti-proliferative effects of DMU-214 and gefitinib are also suggested to be related to the EGFR and EGFRP (phosphorylated epidermal growth factor receptor) expression status since we found significantly weaker cytotoxic activity of the compounds tested in SCC-25 cells, which overexpressed EGFR and EGFRP proteins.<\/jats:p>","DOI":"10.3390\/ijms22126180","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T12:08:55Z","timestamp":1623154135000},"page":"6180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition"],"prefix":"10.3390","volume":"22","author":[{"given":"Malgorzata","family":"Jozkowiak","sequence":"first","affiliation":[{"name":"Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30 St., PL-60-631 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-9004","authenticated-orcid":false,"given":"Marta","family":"Dyszkiewicz-Konwinska","sequence":"additional","affiliation":[{"name":"Department of Biomaterials and Experimental Dentistry, Poznan University of Medical Sciences, Bukowska 70 St., PL-60-812 Poznan, Poland"},{"name":"Department of Anatomy, Poznan University of Medical Sciences, Swiecickiego 6 St., PL-60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ramlau","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30 St., PL-60-631 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-4834","authenticated-orcid":false,"given":"Wieslawa","family":"Kranc","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Poznan University of Medical Sciences, Swiecickiego 6 St., PL-60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spaczynska","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30 St., PL-60-631 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Wierzchowski","sequence":"additional","affiliation":[{"name":"Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6 St., PL-60-780 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6282-3251","authenticated-orcid":false,"given":"Mariusz","family":"Kaczmarek","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Garbary 15 St., PL-61-866 Poznan, Poland"},{"name":"Gene Therapy Unit, Department of Cancer Diagnostics and Immunology, Greater Poland Cancer Centre, Garbary 15 St., PL-61-866 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Jodynis-Liebert","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30 St., PL-60-631 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Piotrowska-Kempisty","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30 St., PL-60-631 Poznan, Poland"},{"name":"Department of Basic and Preclinical Sciences, Institute of Veterinary Medicine, Nicolaus Copernicus University in Toru\u0144, 7 Gagarina St., 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"ref_1","unstructured":"(2021, April 18). International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/today\/online-analysis-table?v=2018&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mrrev.2007.08.004","article-title":"Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad?","volume":"658","author":"Saiko","year":"2008","journal-title":"Mutat. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01635581.2012.667862","article-title":"The anticancer effects of resveratrol: Modulation of transcription factors","volume":"64","author":"Whitlock","year":"2012","journal-title":"Nutr. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1016\/j.ejmech.2011.03.049","article-title":"Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: Structural requirements for potency","volume":"46","author":"Androutsopoulos","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"32627","DOI":"10.1038\/srep32627","article-title":"3\u2032-hydroxy-3,4,5,4\u2032-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model","volume":"6","author":"Borys","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR signaling pathway in cancer therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ejca.2009.02.027","article-title":"EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma","volume":"45","author":"Ryott","year":"2009","journal-title":"Eur. J. Cancer."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13564","DOI":"10.1038\/s41598-019-49885-5","article-title":"Analyzing expression and phosphorylation of the EGF receptor in HNSCC","volume":"9","author":"Kriegs","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","article-title":"Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer","volume":"21","author":"Mendelsohn","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-1-11","article-title":"The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications","volume":"1","author":"Zimmermann","year":"2006","journal-title":"Radiat. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/jcp.22574","article-title":"HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT","volume":"226","author":"Bruzzese","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0973-1482.147380","article-title":"The effects of combination of gefitinib and cisplatin on tongue squamous cell carcinoma cell lines","volume":"11","author":"Helal","year":"2015","journal-title":"J. Can. Res. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2131\/jts.44.435","article-title":"The anti-cancer drug gefitinib accelerates Fas-mediated apoptosis by enhancing caspase-8 activation in cancer cells","volume":"44","author":"Sekiguchi","year":"2019","journal-title":"J. Toxicol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/ar.20938","article-title":"Gefitinib inhibits the proliferation of pancreatic cancer cells via cell cycle arrest","volume":"292","author":"Zhou","year":"2009","journal-title":"Anat. Rec."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.taap.2012.05.023","article-title":"Resveratrol analogue 3,4,4\u2019,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells","volume":"263","author":"Piotrowska","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Purba, E.R., Saita, E.I., and Maruyama, I.N. (2017). Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The \u201cRotation Model\u201d. Cells, 6.","DOI":"10.20944\/preprints201705.0212.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mc.22475","article-title":"Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model","volume":"56","author":"Bauer","year":"2017","journal-title":"Mol. Carcinog."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mi.11.1.4","article-title":"STAT3 signaling: Anticancer strategies and challenges","volume":"11","author":"Johnston","year":"2011","journal-title":"Mol. Interv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3892\/ol.2016.5110","article-title":"The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC","volume":"12","author":"Li","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.omto.2020.06.004","article-title":"Dual Inhibition of MAPK and JAK2\/STAT3 Pathways Is Critical for the Treatment of BRAF Mutant Melanoma","volume":"18","author":"Zhao","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Perner, F., Perner, C., Ernst, T., and Heidel, F.H. (2019). Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation. Cells, 8.","DOI":"10.3390\/cells8080854"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14728222.2011.541440","article-title":"EGFR\u2013PI3K\u2013AKT\u2013mTOR signaling in head and neck squamous cell carcinomas: Attractive targets for molecular-oriented therapy","volume":"15","author":"Freudlsperger","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_26","first-page":"783","article-title":"PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)","volume":"19","author":"Xie","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/REP-09-0314","article-title":"Protein kinase A and protein kinase C(alpha)\/PPP1CC2 play opposing roles in the regulation of phosphatidylinositol 3-kinase activation in bovine sperm","volume":"140","author":"Rotman","year":"2010","journal-title":"Reproduction"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"756134","DOI":"10.1155\/2013\/756134","article-title":"AKT kinase pathway: A leading target in cancer research","volume":"2013","author":"Kumar","year":"2013","journal-title":"Sci. World J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2147\/OTT.S161109","article-title":"Role of the NF\u03baB-signaling pathway in cancer","volume":"11","author":"Xia","year":"2018","journal-title":"Onco Targets Ther."},{"key":"ref_30","first-page":"re13","article-title":"Regulation and function of IKK and IKK-related kinases","volume":"2006","author":"Karin","year":"2006","journal-title":"Sci. STKE"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2008.17.0530","article-title":"Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck","volume":"27","author":"Stewart","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:00Z","timestamp":1760163120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22126180"],"URL":"https:\/\/doi.org\/10.3390\/ijms22126180","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}